CAS 209733-45-9

2-Pyrrolidinecarboxamide, N-[3-[[4-(aminoiminomethyl)benzoyl]amino]propyl]-1-[[2,4-dichloro-3-[[(2,4-dimethyl-8-quinolinyl)oxy]methyl]phenyl]sulfonyl]-, (2S)-

CAS : 209733-45-9

Formule : C₃₄H₃₆Cl₂N₆O₅S

Masse moléculaire : 711.6578

Ref: IN-DA002KDA

Anatibant

CAS : 209733-45-9

Anatibant is a dextran sulfate that binds to the bradykinin b2 receptor. It has been shown to have no significant efficacy in the treatment of inflammatory diseases in rats. Anatibant was found to be ineffective in treating sciatic nerve injury and is not effective for reducing brain damage from ischemia. Anatibant is a low potency compound with a high molecular weight, which makes it poorly absorbed by the body. Anatibant does not bind specifically to any receptor and does not show any significant pharmacological activity.

Degré de pureté : Min. 95%

Ref: 3D-FC176241

Anatibant

CAS : 209733-45-9

Anatibant: a strong non-peptide, inhibits bradykinin B2; lowers brain swelling and damage post-trauma.

Formule : C₃₄H₃₆Cl₂N₆O₅S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 711.66

Ref: TM-T26627